HCPCS drug code · CMS crosswalk
Haloperidol Decanoate J-Code / HCPCS Code
In short
Haloperidol Decanoate is billed under HCPCS J1631 — Injection, haloperidol decanoate, per 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 51 Haloperidol Decanoate NDCs under this code.
Reference
- J1631
- Injection, haloperidol decanoate, per 50 mgBilling unit: 50 mg
- Labelers
- Armas Pharmaceuticals Inc.; BluePoint Laboratories; Caplin Steriles USA Inc.; FreseniUS Kabi USA, LLC; Hikma Pharmaceuticals USA Inc.; Lifestar Pharma; Meitheal Pharmaceuticals Inc.; Mylan Institutional LLCand 5 more
Medicare Part B payment limit
CMS ASP filePayment limit per unit$4.847
Per50 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Haloperidol Decanoate units and claim line
Enter the dose given to get the J1631 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Haloperidol Decanoate NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9295-01 | J1631 | Hikma Pharmaceuticals USA Inc. | 1 | 2 |
| 00143-9296-01 | J1631 | Hikma Pharmaceuticals USA Inc. | 5 | 10 |
| 10147-0921-03 | J1631 | Patriot Pharmaceuticals, LLC | 3 × 1 | 3 |
| 10147-0922-05 | J1631 | Patriot Pharmaceuticals, LLC | 5 × 1 | 10 |
| 25021-0831-01 | J1631 | Sagent Pharmaceuticals | 10 × 1 | 10 |
| 25021-0833-01 | J1631 | Sagent Pharmaceuticals | 10 × 1 | 20 |
| 25021-0834-05 | J1631 | Sagent Pharmaceuticals | 5 | 10 |
| 63323-0469-01 | J1631 | FreseniUS Kabi USA, LLC | 1 | 1 |
| 63323-0469-05 | J1631 | FreseniUS Kabi USA, LLC | 5 | 5 |
| 63323-0471-01 | J1631 | FreseniUS Kabi USA, LLC | 1 | 2 |
| 63323-0471-05 | J1631 | FreseniUS Kabi USA, LLC | 5 | 10 |
| 63323-0471-41 | J1631 | FreseniUS Kabi USA, LLC | 1 | 2 |
| 65145-0167-10 | J1631 | Caplin Steriles USA Inc. | 10 × 1 | 20 |
| 65145-0168-10 | J1631 | Caplin Steriles USA Inc. | 10 × 1 | 10 |
| 65145-0169-01 | J1631 | Caplin Steriles USA Inc. | 5 | 10 |
| 67457-0409-13 | J1631 | Mylan Institutional LLC | 5 × 1 | 10 |
| 67457-0410-13 | J1631 | Mylan Institutional LLC | 10 × 1 | 10 |
| 68001-0578-48 | J1631 | BluePoint Laboratories | 3 × 1 | 3 |
| 68001-0579-48 | J1631 | BluePoint Laboratories | 5 × 1 | 10 |
| 68001-0580-41 | J1631 | BluePoint Laboratories | 1 | 1 |
| 68001-0581-41 | J1631 | BluePoint Laboratories | 1 | 2 |
| 68001-0581-48 | J1631 | BluePoint Laboratories | 5 × 1 | 10 |
| 68001-0581-82 | J1631 | BluePoint Laboratories | 10 × 1 | 20 |
| 68001-0582-41 | J1631 | BluePoint Laboratories | 5 | 10 |
| 68001-0657-51 | J1631 | BluePoint Laboratories | 3 × 1 | 3 |
| 68001-0658-41 | J1631 | BluePoint Laboratories | 1 | 2 |
| 68001-0658-52 | J1631 | BluePoint Laboratories | 5 × 1 | 10 |
| 68001-0659-41 | J1631 | BluePoint Laboratories | 5 | 10 |
| 70069-0030-03 | J1631 | Somerset Pharma, LLC | 3 × 1 | 3 |
| 70069-0031-05 | J1631 | Somerset Pharma, LLC | 5 × 1 | 10 |
| 70069-0381-01 | J1631 | Somerset Pharma, LLC | 1 | 1 |
| 70069-0381-10 | J1631 | Somerset Pharma, LLC | 10 × 1 | 10 |
| 70069-0383-01 | J1631 | Somerset Pharma, LLC | 1 | 2 |
| 70069-0383-05 | J1631 | Somerset Pharma, LLC | 5 × 1 | 10 |
| 70069-0384-01 | J1631 | Somerset Pharma, LLC | 5 | 10 |
| 70710-1461-06 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 10 × 1 | 10 |
| 70710-1461-09 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 3 × 1 | 3 |
| 70710-1463-01 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 1 | 2 |
| 70710-1463-05 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 5 × 1 | 10 |
| 70710-1464-01 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 5 | 10 |
| 70710-1464-05 | J1631 | Zydus Pharmaceuticals (USA) Inc. | 5 × 5 | 50 |
| 70756-0615-10 | J1631 | Lifestar Pharma | 10 × 1 | 10 |
| 70756-0615-81 | J1631 | Lifestar Pharma | 1 | 1 |
| 70756-0616-10 | J1631 | Lifestar Pharma | 10 × 1 | 20 |
| 70756-0616-81 | J1631 | Lifestar Pharma | 1 | 2 |
| 70756-0625-85 | J1631 | Lifestar Pharma | 5 | 10 |
| 71288-0502-02 | J1631 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 10 |
| 71288-0503-02 | J1631 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 20 |
| 71288-0504-05 | J1631 | Meitheal Pharmaceuticals Inc. | 5 | 10 |
| 72485-0520-10 | J1631 | Armas Pharmaceuticals Inc. | 10 × 1 | 10 |
| 72603-0230-01 | J1631 | Northstar RxLLC | 1 | 2 |
Haloperidol Decanoate: common questions
- What is the J-code for Haloperidol Decanoate?
- Haloperidol Decanoate is billed under HCPCS J1631 — Injection, haloperidol decanoate, per 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 51 Haloperidol Decanoate NDCs under this code.
- How many J1631 billing units are in a package of Haloperidol Decanoate?
- CMS lists 1 to 50 billing units per package, depending on the NDC, where one unit is 50 mg. Units to report are based on the dose given, not the package.
- Is J1631 a CPT code?
- No. J1631 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.